Analysts have handed AbbVie a consensus “Moderate Buy” rating, reflecting cautious optimism about its future performance. Out ...

IFM Investors boosted its stake in Amgen by nearly 9%, bringing its holdings to $36 million. Amgen delivered a strong ...

When it comes to which "Magnificent Seven" stock is the best to buy, I think the answer is clear: Alphabet (GOOGL 0.54%) ...